HomeMy WebLinkAbout2021_9_11 JJaman_COVIDFrom:Julie Jaman
To:jeffbocc; Board of Health; Allison Berry; Karen Obermeyer
Subject:protocols to help stop shedding
Date:Saturday, September 11, 2021 1:36:48 PM
CAUTION: This email originated from outside your organization. Exercise caution when opening attachments or clickinglinks, especially from unknown senders.
Hello AllWe who do not go to the hospital need protocols on howto care for ourselves at home. Please.
This is helpful information about "... reducing viral shedding among
nonhospitalized patients with mild to moderate COVID-19."
Provide some choices and options please.
JulieJaman360-385-6078
https://www.jpost.com/health-science/israeli-scientist-says-covid-19-could-be-treated-for-under-1day-675612
Double-blind study shows ivermectin reduces disease’s duration and infectiousness • FDA and WHO
caution against its use
By MAAYAN JAFFE-HOFFMAN AUGUST 2, 2021 21:01
......................
" “It also shows that there is almost a 100% chance that a person will be noninfectious in
four to six days, which could lead to shortening isolation time for these people. This could
have a huge economic and social impact.”
..................................
"During Schwartz’s study, there was not any signal of significant side effects among
ivermectin users.
" ivermectin ‘demonstrates a strong signal of therapeutic
efficacy’ against COVID-19.”
"IN CONTRAST, Schwartz said he was very disappointed that the WHO did not support
any trial to determine whether the drug could be viable.
"You would think Merck would be happy to hear that ivermectin might be helpful to corona
patients and try to study it, but they are most loudly declaring the drug should not be used,”
Schwartz said. “A billion people took it. They gave it to them. It’s a real shame.” (jj: now
banned as prescription drug in US)
And not moving forward with ivermectin could potentially extend the time it takes for the
world to be able to live alongside the virus, he said.
"“Developing new medications can take years; therefore, identifying existing drugs that can
be re-purposed against COVID-19 [and] that already have an established safety profile
through decades of use could play a critical role in suppressing or even ending the SARS-
CoV-2 pandemic,” wrote the researchers in the American Journal of Therapeutics. “Using
re-purposed medications may be especially important because it could take months,
possibly years, for much of the world’s population to get vaccinated, particularly among low-
to middle-income populations.”